Literature DB >> 28243186

A Framework of Care in Multiple Sclerosis, Part 2: Symptomatic Care and Beyond.

Scott D Newsome, Philip J Aliotta, Jacquelyn Bainbridge, Susan E Bennett, Gary Cutter, Kaylan Fenton, Fred Lublin, Dorothy Northrop, David Rintell, Bryan D Walker, Megan Weigel, Kathleen Zackowski, David E Jones.   

Abstract

The Consortium of Multiple Sclerosis Centers (CMSC) convened a Framework Taskforce composed of a multidisciplinary group of clinicians and researchers to examine and evaluate the current models of care in multiple sclerosis (MS). The methodology of this project included analysis of a needs assessment survey and an extensive literature review. The outcome of this work is a two-part continuing education series of articles. Part 1, published previously, covered the updated disease phenotypes of MS along with recommendations for the use of disease-modifying therapies. Part 2, presented herein, reviews the variety of symptoms and potential complications of MS. Mobility impairment, spasticity, pain, fatigue, bladder/bowel/sexual dysfunction, cognitive dysfunction, and neuropsychiatric issues are examined, and both pharmacologic and nonpharmacologic interventions are described. Because bladder and bowel symptoms substantially affect health-related quality of life, detailed information about elimination dysfunction is provided. In addition, a detailed discussion about mental health and cognitive dysfunction in people with MS is presented. Part 2 concludes with a focus on the role of rehabilitation in MS. The goal of this work is to facilitate the highest levels of independence or interdependence, function, and quality of life for people with MS.

Entities:  

Year:  2017        PMID: 28243186      PMCID: PMC5315323          DOI: 10.7224/1537-2073.2016-062

Source DB:  PubMed          Journal:  Int J MS Care        ISSN: 1537-2073


  29 in total

1.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

Review 2.  Therapeutics for multiple sclerosis symptoms.

Authors:  Aliza Bitton Ben-Zacharia
Journal:  Mt Sinai J Med       Date:  2011 Mar-Apr

3.  The effect of functional electrical stimulation on the physiological cost of gait in people with multiple sclerosis.

Authors:  L Paul; D Rafferty; S Young; L Miller; P Mattison; A McFadyen
Journal:  Mult Scler       Date:  2008-06-23       Impact factor: 6.312

4.  Care patterns in multiple sclerosis: principal care, comprehensive team care, consortium care.

Authors:  J Halper; J S Burks
Journal:  NeuroRehabilitation       Date:  1994       Impact factor: 2.138

5.  Does hippotherapy effect use of sensory information for balance in people with multiple sclerosis?

Authors:  Jodi L Lindroth; Jessica L Sullivan; Debbie Silkwood-Sherer
Journal:  Physiother Theory Pract       Date:  2015-10-14       Impact factor: 2.279

6.  An examination of suicidal intent in patients with multiple sclerosis.

Authors:  Anthony Feinstein
Journal:  Neurology       Date:  2002-09-10       Impact factor: 9.910

7.  Balance exercise program reduced falls in people with multiple sclerosis: a single-group, pretest-posttest trial.

Authors:  Ylva Elisabet Nilsagård; Lena Kristina von Koch; Malin Nilsson; Anette Susanne Forsberg
Journal:  Arch Phys Med Rehabil       Date:  2014-07-06       Impact factor: 3.966

8.  Causes of death among persons with multiple sclerosis.

Authors:  Gary R Cutter; Jeffrey Zimmerman; Amber R Salter; Volker Knappertz; Gustavo Suarez; John Waterbor; Virginia J Howard; Ruth Ann Marrie
Journal:  Mult Scler Relat Disord       Date:  2015-07-18       Impact factor: 4.339

9.  Reduction in disability in a randomized controlled trial of telephone-administered cognitive-behavioral therapy.

Authors:  David C Mohr; Stacey Hart; Lea Vella
Journal:  Health Psychol       Date:  2007-09       Impact factor: 4.267

10.  Physical disability, anxiety and depression in people with MS: an internet-based survey via the UK MS Register.

Authors:  Kerina H Jones; Philip A Jones; Rodden M Middleton; David V Ford; Katie Tuite-Dalton; Hazel Lockhart-Jones; Jeffrey Peng; Ronan A Lyons; Ann John; J Gareth Noble
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

View more
  7 in total

Review 1.  Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.

Authors:  Graziella Filippini; Silvia Minozzi; Francesca Borrelli; Michela Cinquini; Kerry Dwan
Journal:  Cochrane Database Syst Rev       Date:  2022-05-05

Review 2.  Siponimod for multiple sclerosis.

Authors:  Liujiao Cao; Meixuan Li; Liang Yao; Peijing Yan; Xiaoqin Wang; Zhen Yang; Yongfeng Lao; Huijuan Li; Kehu Yang; Ka Li
Journal:  Cochrane Database Syst Rev       Date:  2021-11-16

Review 3.  Therapies for mobility disability in persons with multiple sclerosis.

Authors:  Jessica F Baird; Brian M Sandroff; Robert W Motl
Journal:  Expert Rev Neurother       Date:  2018-05-30       Impact factor: 4.618

4.  Cognitive Behavioral Therapy for the Management of Multiple Sclerosis-Related Pain: A Randomized Clinical Trial.

Authors:  Elizabeth S Gromisch; Robert D Kerns; Rebecca Czlapinski; Beth Beenken; John Otis; Albert C Lo; John Beauvais
Journal:  Int J MS Care       Date:  2020 Jan-Feb

5.  Anorectal dysfunction in multiple sclerosis patients: A pilot study on the effect of an individualized rehabilitation approach.

Authors:  Martina Kovari; Jan Stovicek; Jakub Novak; Michaela Havlickova; Sarka Mala; Andrew Busch; Pavel Kolar; Alena Kobesova
Journal:  NeuroRehabilitation       Date:  2022       Impact factor: 2.138

6.  Training Neurodegenerative Disease Support Group Leaders: A New Support Group Functioning Scale.

Authors:  Therese V Cash; Christopher Kilbourn; Sarah K Lageman
Journal:  Gerontol Geriatr Med       Date:  2018-11-20

7.  Prioritizing the healthcare access concerns of Canadians with MS.

Authors:  Julie Pétrin; Mary Ann McColl; Catherine Donnelly; Simon French; Marcia Finlayson
Journal:  Mult Scler J Exp Transl Clin       Date:  2021-07-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.